These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 831078)

  • 1. Human disease transferred to mice: myasthenia gravis.
    Dawson DM
    N Engl J Med; 1977 Jan; 296(3):168-9. PubMed ID: 831078
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Cause of weakness in myasthenia gravis.
    Grob D
    N Engl J Med; 1976 Mar; 294(13):722-3. PubMed ID: 1082544
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis.
    Cuénoud S; Feltkamp TE; Fulpius BW; Oosterhuis HJ
    Neurology; 1980 Feb; 30(2):201-2. PubMed ID: 7188802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disorders of receptor function as a pathogenetic principle in myasthenia gravis].
    Toyka KV
    Internist (Berl); 1988 Jun; 29(6):414-9. PubMed ID: 3042682
    [No Abstract]   [Full Text] [Related]  

  • 5. Myasthenia gravis (first of two parts).
    Drachman DB
    N Engl J Med; 1978 Jan; 298(3):136-42. PubMed ID: 201840
    [No Abstract]   [Full Text] [Related]  

  • 6. Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome.
    Lindstrom JM; Lambert EH
    Neurology; 1978 Feb; 28(2):130-8. PubMed ID: 202890
    [No Abstract]   [Full Text] [Related]  

  • 7. Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. II. Receptor synthesis.
    Wilson S; Vincent A; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1983 May; 46(5):383-7. PubMed ID: 6101172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity in ocular and generalised myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT; Lawton J; Luciani G; McLeod J; Bradley J; Genkins G; Teng CS
    J Neuroimmunol; 1981 Sep; 1(3):325-32. PubMed ID: 7334085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies in myasthenia gravis: demonstration of anti-motor endplate antibody and anti-muscle membrane antibody using membrane immunofluorescence technique.
    Arimori S; Tada S; Nakata Y; Kobashi H; Ichikawa Y
    Acta Med Okayama; 1975 Dec; 29(6):397-404. PubMed ID: 132840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of neonatal myasthenia gravis and unsuspectedly long duration of neuromuscular block in distal muscles.
    Desmedt JE; Borenstein S
    N Engl J Med; 1977 Mar; 296(11):633. PubMed ID: 190536
    [No Abstract]   [Full Text] [Related]  

  • 11. Short review of progress in experimental myasthenia gravis, bearing on the pathogenesis of myasthenia gravis.
    Heilbronn E
    Prog Brain Res; 1979; 49():459-63. PubMed ID: 390612
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)].
    Hohlfeld R; Wekerle H
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunopathology of myasthenia gravis.
    Engel AG
    Int J Neurol; 1980; 14(1):35-46. PubMed ID: 6293990
    [No Abstract]   [Full Text] [Related]  

  • 14. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model.
    Toyka KV; Birnberger KL; Anzil AP; Schlegel C; Besinger U; Struppler A
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):746-53. PubMed ID: 210263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle acetylcholine receptor loss in murine experimental autoimmune myasthenia gravis: correlated with cellular, humoral and clinical responses.
    Christadoss P; Lindstrom J; Munro S; Talal N
    J Neuroimmunol; 1985 Apr; 8(1):29-41. PubMed ID: 3973007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of immune complexes at the motor endplate in myasthenia gravis].
    Tsujihata M; Yoshimura T; Satoh A; Hazama R; Mori M
    Rinsho Shinkeigaku; 1983 Sep; 23(9):735-43. PubMed ID: 6673871
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Acetylcholine-receptor-blocking factor and striated-muscle antibody in myasthenia gravis.
    Strauss AJ
    Lancet; 1976 Jun; 1(7974):1405-6. PubMed ID: 59037
    [No Abstract]   [Full Text] [Related]  

  • 19. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.
    Mossman S; Vincent A; Newsom-Davis J
    Lancet; 1986 Jan; 1(8473):116-9. PubMed ID: 2417076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental myasthenia gravis: a model of receptor disease.
    Takamori M; Kasai M
    Int J Neurol; 1980; 14(1):47-60. PubMed ID: 6293991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.